Merck Gets CHMP Positive Opinion For KEYTRUDA For Advanced Non-Small Cell Lung Cancer Treatment
June 27, 2016 at 08:41 AM EDT
Merck & Co., Inc. (NYSE: MRK) disclosed Monday that the Committee for Medicinal Products for Human Use (CHMP) of the European ...